Misplaced Pages

Indium (111In) altumomab pentetate (INN) (USP, indium In 111 altumomab pentetate; trade name Hybri-ceaker) is a mouse monoclonal antibody linked to pentetate which acts as a chelating agent for the radioisotope indium-111. The drug is used for the diagnosis of colorectal cancer but has not been approved for use.

References

1. "lnternational Nonproprietary Names for Pharmaceutical Substances" (PDF). WHO Drug Information. 7 (3). 1993. Archived from the original (PDF) on 2012-02-19. Retrieved 2009-09-22.
2. "Cumulartive [sic] Designated Products List". U.S. Food and Drug Administration. Archived from the original on 26 October 2012 – via Scribd Inc.
3. Kim EE (2001). "Radioimmunodetection of Cancer". Targeted Molecular Imaging in Oncology. New York, NY: Springer. pp. 88-101 (92). ISBN 9780387950280.

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

This nuclear medicine article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Drugs not assigned an ATC code
• Monoclonal antibodies for tumors
• Indium compounds
• Antibody-drug conjugates
• Radiopharmaceuticals
• Monoclonal antibody stubs
• Antineoplastic and immunomodulating drug stubs
• Nuclear medicine stubs